These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Reflux oesophagitis in children; the role of endoscopy. A multicentric Italian survey. Lombardi G; de' Angelis G; Rutigliano V; Guariso G; Romano C; Falchetti D; Pittschieler K; Brunero M; Lerro P; Sabbi T; Pepe G; De Venuto D; Torroni F; Bizzarri B; Di Nicola M; Di Mascio R; Dall'Oglio L Dig Liver Dis; 2007 Sep; 39(9):864-71. PubMed ID: 17681873 [TBL] [Abstract][Full Text] [Related]
25. [Long-term course of reflux symptoms following Helicobacter pylori eradication]. Peitz U; Raps S; Plein K; Leodolter A; Hotz Dagger J; Malfertheiner P Dtsch Med Wochenschr; 2004 Mar; 129(13):671-5. PubMed ID: 15026962 [TBL] [Abstract][Full Text] [Related]
26. Multivariate analysis of the association of acid and duodeno-gastro-oesophageal reflux exposure with the presence of oesophagitis, the severity of oesophagitis and Barrett's oesophagus. Koek GH; Sifrim D; Lerut T; Janssens J; Tack J Gut; 2008 Aug; 57(8):1056-64. PubMed ID: 18403496 [TBL] [Abstract][Full Text] [Related]
27. Review article: intragastric and oesophageal pH monitoring in patients with gastro-oesophageal reflux disease. Katz PO Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():3-11. PubMed ID: 16483265 [TBL] [Abstract][Full Text] [Related]
30. Clinical use of antacids. Halter F J Physiol Pharmacol; 1993 Sep; 44(3 Suppl 1):61-74. PubMed ID: 8260736 [TBL] [Abstract][Full Text] [Related]
31. Natural history of gastro-oesophageal reflux disease without oesophagitis (NERD)--a reappraisal 10 years on. Pace F; Bollani S; Molteni P; Bianchi Porro G Dig Liver Dis; 2004 Feb; 36(2):111-5. PubMed ID: 15002817 [TBL] [Abstract][Full Text] [Related]
32. Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations? Frazzoni M; Manno M; De Micheli E; Savarino V Dig Liver Dis; 2006 Sep; 38(9):643-8. PubMed ID: 16627016 [TBL] [Abstract][Full Text] [Related]
33. Physiological studies on nitric oxide in the lower esophageal sphincter of patients with reflux esophagitis. Tomita R; Tanjoh K; Fujisaki S; Fukuzawa M Hepatogastroenterology; 2003; 50(49):110-4. PubMed ID: 12630004 [TBL] [Abstract][Full Text] [Related]
34. Bile and acid reflux in the pathogenesis of reflux oesophagitis in children. Jiang M; Chen J; Chen F; Yu J; Liang J; Zhang Y; Ou B J Paediatr Child Health; 2009; 45(1-2):64-7. PubMed ID: 19208069 [TBL] [Abstract][Full Text] [Related]
35. [Pelotherapy in the overall treatment of peptic ulcer with accompanying reflux esophagitis]. Serebrina LA; Mavrodiĭ VM Vopr Kurortol Fizioter Lech Fiz Kult; 1978; (3):47-9. PubMed ID: 27005 [No Abstract] [Full Text] [Related]
36. Oesophageal damage and defence in reflux oesophagitis: pathophysiological and cell biological mechanisms. Hopwood D Prog Histochem Cytochem; 1997; 32(3-4):1-42. PubMed ID: 9551487 [No Abstract] [Full Text] [Related]
38. [Pathophysiology of the harmful influence of smoking on the course of gastric and duodenal ulcer diseases]. Budzyński J; Swiatkowski M Przegl Lek; 1996; 53(11):811-5. PubMed ID: 9173445 [TBL] [Abstract][Full Text] [Related]
40. [The current physiopathological, diagnostic, clinical and therapeutic considerations of peptic ulcer. A comparison between traditional and modern therapeutic methods]. Pace V; Artico M; Ciccariello M; Bonanni G Minerva Dietol Gastroenterol; 1990; 36(2):63-75. PubMed ID: 2247261 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]